Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 9.76% is 64996% above its 5-year average of 0.01%, near the high end of its 5-year range (-83.33%–9.76%).
As of the fiscal period ended Tuesday, June 30, 2026. 48.90% above its 12-month average of 6.56%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 9.76%.
RETURN ON INVESTED CAPITAL (ROIC)
9.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
6.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
0.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
0.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+48.90%
CURRENT VS 3Y AVG
+24609.44%
CURRENT VS 5Y AVG
+64996.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+127.38%
vs the sector median at left
Kiniksa Pharmaceuticals International, plc
Market Cap
$5.87B
Return on Invested Capital (ROIC)
9.76%
TTM Avg
6.56%
3Y Avg
0.04%
5Y Avg
0.01%
Market Cap
$5.89B
Return on Invested Capital (ROIC)
-20.26%
TTM Avg
-47.02%
3Y Avg
-56.93%
5Y Avg
-48.62%
Market Cap
$5.95B
Return on Invested Capital (ROIC)
3.91%
TTM Avg
0.53%
3Y Avg
0.65%
5Y Avg
2.31%
Market Cap
$5.79B
Return on Invested Capital (ROIC)
-37.26%
TTM Avg
-50.97%
3Y Avg
-60.09%
5Y Avg
-54.48%
Market Cap
$5.78B
Return on Invested Capital (ROIC)
-115.23%
TTM Avg
-66.98%
3Y Avg
-62.66%
5Y Avg
-49.24%
Market Cap
$5.61B
Return on Invested Capital (ROIC)
-24.33%
TTM Avg
-20.36%
3Y Avg
-23.88%
5Y Avg
-23.64%
Market Cap
$5.53B
Return on Invested Capital (ROIC)
1.41%
TTM Avg
2.38%
3Y Avg
2.50%
5Y Avg
2.69%
Market Cap
$6.23B
Return on Invested Capital (ROIC)
-63.96%
TTM Avg
-73.62%
3Y Avg
-66.48%
5Y Avg
-67.69%
Market Cap
$5.52B
Return on Invested Capital (ROIC)
0.43%
TTM Avg
-2.29%
3Y Avg
-2.17%
5Y Avg
-2.17%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | $5.87B | 9.76% | 6.56% | 0.04% | 0.01% |
| GRAIL Inc. (GRAL)vs › | $5.89B | -20.26% | -47.02% | -56.93% | -48.62% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 3.91% | 0.53% | 0.65% | 2.31% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | -37.26% | -50.97% | -60.09% | -54.48% |
| Kodiak Sciences Inc. (KOD)vs › | $5.78B | -115.23% | -66.98% | -62.66% | -49.24% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -24.33% | -20.36% | -23.88% | -23.64% |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.41% | 2.38% | 2.50% | 2.69% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | -63.96% | -73.62% | -66.48% | -67.69% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 0.43% | -2.29% | -2.17% | -2.17% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 4.59% | 5.84% | -12.63% | -15.96% |
ROIC
9.8%
ROE
12.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 9.76% |
| 2026-03-31 | 9.61% |
| 2025-12-31 | 8.17% |
| 2025-09-30 | 4.79% |
| 2025-06-30 | 0.45% |
| 2025-03-31 | -3.15% |
| 2024-12-31 | -9.50% |
| 2024-09-30 | -5.71% |
| 2024-06-30 | -6.00% |
| 2024-03-31 | -6.71% |
| 2023-12-31 | -5.45% |
| 2023-09-30 | -4.48% |
| 2023-06-30 | 8.72% |
| 2023-03-31 | 5.39% |
| 2022-12-31 | 2.37% |
| 2022-09-30 | -8.03% |
| 2022-06-30 | -65.55% |
| 2022-03-31 | -72.35% |
| 2021-12-31 | -83.33% |
| 2021-09-30 | -79.39% |
| 2021-06-30 | -77.34% |
| 2021-03-31 | -64.29% |
| 2020-12-31 | -49.54% |
| 2020-09-30 | -37.96% |
| 2020-06-30 | -49.20% |
| 2020-03-31 | -63.70% |
| 2019-12-31 | -74.97% |
| 2019-09-30 | -71.39% |
| 2019-06-30 | -63.76% |
| 2019-03-31 | -51.56% |
| 2018-12-31 | -38.71% |
| 2018-09-30 | -30.32% |
| 2018-06-30 | -25.39% |
| 2018-03-31 | -37.32% |
| 2017-12-31 | -217.55% |
